Circulation, Vol 74, 1255-1265, Copyright © 1986 by American Heart Association
JC Kaski, F Crea, D Meran, L Rodriguez, L Araujo, S Chierchia, G Davies and A Maseri
It has been shown in different groups of patients with variant angina that
coronary spasm can be reproduced by physiologic maneuvers and pharmacologic
agents. It is not known, however, to what extent different stimuli can
induce spasm in the same patient. To investigate whether coronary arterial
spasm results from specific abnormal agonist- receptor interactions or from
a local nonspecific coronary supersensitivity to different stimuli, 28
patients with vasospastic angina were submitted to a series of diverse
vasoconstrictive stimuli known to provoke coronary spasm. Ergonovine,
hyperventilation, handgrip, cold pressor, and exercise-tests, were carried
out in all 28 patients. In the last 15 patients histamine was also
administered. Spasm was provoked by ergonovine in 96% of patients, by
hyperventilation in 54%, by histamine in 47%, by exercise in 46%, and by
the cold pressor and handgrip tests in 11% and 7%, respectively. No
significant differences were found in the responses to provocative tests of
patients with normal coronary arteries or nonsignificant stenoses and those
with significant lesions. In the same individual, spasm was induced by at
least two vasoconstrictive stimuli, although with a different mechanism of
action, in 82% of patients and spasm was induced by three or more stimuli
in 39%. Tests were repeated in at least 23 patients and short-term
reproducibility paralleled sensitivity. These results suggest that in
patients with variant angina, a local nonspecific supersensitivity rather
than an abnormal specific agonist-receptor interaction plays a major role
in the genesis of coronary arterial spasm.
ARTICLES
Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina
This article has been cited by other articles:
![]() |
P. K. Mishra Variations in presentation and various options in management of variant angina. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 748 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E Price Heart disease and work Heart, September 1, 2004; 90(9): 1077 - 1084. [Full Text] [PDF] |
||||
![]() |
A.-L. Hemdahl, E. Falk, P. Thoren, and G. K. Hansson Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H872 - H877. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sueda, H. Kohno, H. Fukuda, N. Ochi, H. Kawada, Y. Hayashi, and T. Uraoka Frequency of Provoked Coronary Spasms in Patients Undergoing Coronary Arteriography Using a Spasm Provocation Test Via Intracoronary Administration of Ergonovine Angiology, July 1, 2004; 55(4): 403 - 411. [Abstract] [PDF] |
||||
![]() |
S. Sueda, H. Kohno, H. Fukuda, K. Watanabe, N. Ochi, H. Kawada, and T. Uraoka Limitations of Medical Therapy in Patients With Pure Coronary Spastic Angina Chest, February 1, 2003; 123(2): 380 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawano, T. Motoyama, H. Yasue, N. Hirai, H. M. Waly, K. Kugiyama, and H. Ogawa Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina J. Am. Coll. Cardiol., July 17, 2002; 40(2): 266 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanabe, E. Itoh, K. Suzuki, M. Ito, Y. Hosaka, I. Nakagawa, and M. Kumakura Limited role of coronary angioplasty and stentingin coronary spastic angina with organic stenosis J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1120 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Minshall, D. Pavcnik, P. V. Halushka, and K. Hermsmeyer Progesterone regulation of vascular thromboxane A2 receptors in rhesus monkeys Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1498 - H1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kinlay, D. Behrendt, M. Wainstein, J. Beltrame, J. C. Fang, M. A. Creager, A. P. Selwyn, and P. Ganz Role of Endothelin-1 in the Active Constriction of Human Atherosclerotic Coronary Arteries Circulation, September 4, 2001; 104(10): 1114 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okumura, T. Osanai, T. Kosugi, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, T. Miura, T. Hatayama, T. Nakano, et al. Enhanced phospholipase C activity in the cultured skin fibroblast obtained from patients with coronary spastic angina: possible role for enhanced vasoconstrictor response J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1847 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Minshall, F. Z. Stanczyk, K. Miyagawa, B. Uchida, M. Axthelm, M. Novy, and K. Hermsmeyer Ovarian Steroid Protection against Coronary Artery Hyperreactivity in Rhesus Monkeys J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 649 - 659. [Abstract] [Full Text] |
||||
![]() |
K. Shinozaki, Y. Hattori, M. Suzuki, Y. Hara, A. Kanazawa, H. Takaki, M. Tsushima, and Y. Harano Insulin Resistance as an Independent Risk Factor for Carotid Artery Wall Intima Media Thickening in Vasospastic Angina Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3302 - 3310. [Abstract] [Full Text] |
||||
![]() |
J. N. Dalal, J. A. Brinker, and J. R. Resar Coronary Artery Spasm In The Transplanted Human Heart A Case Report Angiology, March 1, 1996; 47(3): 291 - 294. [Abstract] [PDF] |
||||
![]() |
Y. Ozaki, D. Keane, and P. W. Serruys Progression and Regression of Coronary Stenosis in the Long-term Follow-up of Vasospastic Angina Circulation, November 1, 1995; 92(9): 2446 - 2456. [Abstract] [Full Text] |
||||
![]() |
K. Shinozaki, M. Suzuki, M. Ikebuchi, H. Takaki, Y. Hara, M. Tsushima, and Y. Harano Insulin Resistance Associated With Compensatory Hyperinsulinemia as an Independent Risk Factor for Vasospastic Angina Circulation, October 1, 1995; 92(7): 1749 - 1757. [Abstract] [Full Text] |
||||
![]() |
T. Nakano, T. Osanai, H. Tomita, M. Sekimata, Y. Homma, and K. Okumura Enhanced Activity of Variant Phospholipase C-{delta}1 Protein (R257H) Detected in Patients With Coronary Artery Spasm Circulation, April 30, 2002; 105(17): 2024 - 2029. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |